BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference
April 21, 2022 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression
April 06, 2022 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Ontario to Get Dedicated Mental Health Facility for First Responders
March 03, 2022 18:09 ET
|
Police Association of Ontario
Toronto, March 03, 2022 (GLOBE NEWSWIRE) -- The Police Association of Ontario (PAO) is thrilled that Ontario has announced a dedicated mental health facility for first responders thanks to...
BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model
February 15, 2022 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Launches New Corporate Website
February 10, 2022 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Feb. 10, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR/ OTCQB: BETRF/ FRA: NPAU), an emerging biotech company focused on the...
Psychable Founders To Be Featured Speakers At Meet Delic Conference
November 05, 2021 09:29 ET
|
Psychable, Inc.
LOS ANGELES, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Meet Delic is shaping up to be one of the largest psychedelic industry gatherings of the year including Jason Silva, Aubrey Marcus, Dr. Carl Hart,...
COMPASS Pathways launches new podcast “Everyone has a story: talking about mental health”
June 30, 2021 07:00 ET
|
COMPASS Pathfinder Ltd.
London, UK – 30 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression
June 28, 2021 07:00 ET
|
COMPASS Pathfinder Ltd.
London, UK, June 28, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
COMPASS Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Scholars programme
June 23, 2021 07:00 ET
|
COMPASS Pathfinder Ltd.
Programme aims to support students from under-represented ethnic groups London, UK – 23 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to...
COMPASS Pathways plc to participate in JMP Securities and H.C. Wainwright investor conferences
June 08, 2021 07:00 ET
|
COMPASS Pathfinder Ltd.
LONDON, June 08, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...